Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul Beaumont is active.

Publication


Featured researches published by Paul Beaumont.


The Lancet | 1971

GROWTH HORMONE, SORBITOL, AND DIABETIC CAPILLARY DISEASE

Paul Beaumont; P.T. Schofield; Frederick C. Hollows; T.F. Williams; A.W. Steinbeck

Abstract It is suggested that excessive secretion of growth hormone (G.H.) may be the cause of diabetic capillary disease. G.H. hypersecretion inhibits glucose metabolism and results in an accumulation of sorbitol. This in turn causes an osmotic imbalance resulting in damage to tissues.


The Lancet | 1972

CLASSIFICATION OF DIABETIC RETINOPATHY, WITH THERAPEUTIC IMPLICATIONS

Paul Beaumont; Frederick C. Hollows

Abstract A classification of diabetic retinopathy based on clinical observation and investigation is presented. There are four groups: diffuse capillary retinopathy, diabetic lipid retinopathy, diabetic obstructive retinopathy, and minimal diabetic retinopathy. Each group has distinct aetiological features, and the classification can be used to direct therapy.


Diabetes | 1974

Glycogen Accumulation in Retinal Neurons and Glial Cells of Streptozotocin-diabetic Rats: Quantitative Electron Microscopy

Leo Sosula; Paul Beaumont; Frederick C. Hollows; Keith M. Jonson; Hubert L Regtop

The concentration of glycogen β-particles was measured in the inner retinal layers of normal and streptozotocin-diabetic rats with quantitative electron microscopic technics. Diabetes was uncontrolled and of short duration (thirty days). Blood glucose levels in the normal and diabetic animals were 76 ± 8 S.E. and 340 ± 25 S.E. mg./100 ml. Diabetes caused glycogen accumulation in the amacrine, bipolar, ganglionic, Müller and capillary mural cells. Quantitative estimates showed significant increases (p < 0.001) in the glycogen concentrations of cells in the nerve fiber layer (NFL), inner plexiform layer (IPL) and inner nuclear layer (INL) of the diabetic retinas. The glycogen concentrations increased from 6.4 ± 0.41 β-particles per square micron in the normal to 10.5 ± 0.85 in the diabetic Müller endfeet (NFL); from 12.9 ± 1.5 to 38.6 ± 5.0 in the Müller processes (IPL); from 0.81 ± 0.13 to 3.37 ± 0.49 in the neural processes (IPL); from 2.7 ± 0.66 to 17.3 ± 2.4 in the amacrine cell bodies (INL). Diabetic glycogen accumulation occurred at a greater rate in the neurons than in the Müller cells. The amacrine neurons were the most severely affected and contained massive glycogen deposits in their cytoplasm. The glycogen concentration in the neurons was less than that of the Müller cells. However, the Müller cells represent only ∼10 per cent of the total cytoplasm of the IPL, whereas the neurons occupy ∼90 per cent of this layer. From the above data, it is evident that the neurons contain about one third of the total glycogen of the normal IPL. In the diabetic IPL, the total glycogen is approximately evenly distributed between the neural and glial compartments.


Investigative Ophthalmology & Visual Science | 1972

Dilatation and Endothelial Proliferation of Retinal Capillaries in Streptozotocin-Diabetic Rats: Quantitative Electron Microscopy

Leo Sosula; Paul Beaumont; Frederick C. Hollows; Keith M. Jonson


Investigative Ophthalmology & Visual Science | 1972

Quantitative ultrastructure of capillaries in the rat retina.

Leo Sosula; Paul Beaumont; Keith M. Jonson; Frederick C. Hollows


Australian and New Zealand Journal of Ophthalmology | 1996

Activated protein C resistance--low incidence in glaucomatous optic disc haemorrhage and central retinal vein occlusion.

Stuart L. Graham; Ivan Goldberg; Barbara Murray; Paul Beaumont; Beng H. Chong


Australian and New Zealand Journal of Ophthalmology | 1994

Ophthalmodynamometry and corticosteroids in central retinal vein occlusion.

Paul Beaumont; H. Kwon Kang


Ophthalmology | 2014

Is There Risk of Stroke with Aflibercept

Paul Beaumont; Peter Petocz; Hyong K Kang


Australian and New Zealand Journal of Ophthalmology | 1994

Isolated bulbar conjunctival Kaposi's sarcoma.

Neil Murray; Peter McCluskey; Denis Wakefield; Paul Beaumont


Clinical and Experimental Ophthalmology | 2005

Balancing the risks and benefits in AMD

Paul Beaumont; Hyong K Kang

Collaboration


Dive into the Paul Beaumont's collaboration.

Top Co-Authors

Avatar

Frederick C. Hollows

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fred Hollows

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leo Sosula

Australian National University

View shared research outputs
Top Co-Authors

Avatar

A.W. Steinbeck

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Ian Kennedy

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Ivan Goldberg

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Barbara Murray

University of New South Wales

View shared research outputs
Top Co-Authors

Avatar

Beng H. Chong

University of New South Wales

View shared research outputs
Researchain Logo
Decentralizing Knowledge